• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Auna SA

    6/28/24 6:19:58 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care
    Get the next $AUNA alert in real time by email
    SC 13G/A 1 gass-sc13ga2_062824.htm AMENDMENT NO. 2 TO SCHEDULE 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. 2)*

     

    Auna S.A.

    (Name of Issuer)

     

    Class A Ordinary Shares, nominal value US$0.01 per share

    (Title of Class of Securities)

     

    L0415A 103

    (CUSIP Number)

     

    June 27, 2024

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

      

     
     
     

     

     

    CUSIP No. L0415A 103 Page 2 of 10

     

    1 NAMES OF REPORTING PERSONS    
    Grupo Angeles Servicios de Salud, S.A. de C.V.    
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    
    (a) ☐    
    (b) ☐    
    3 SEC USE ONLY    
         
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
    United Mexican States    
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER    
    0    
       
    6 SHARED VOTING POWER    
    4,678,342    
       
    7 SOLE DISPOSITIVE POWER    
    0    
       
    8 SHARED DISPOSITIVE POWER    
    4,678,342    
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
    4,678,342    
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐    
         
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    
    15.6% (1)    
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    
    OO    
       

     

    (1)The calculation assumes that there is a total of 30,000,000 Class A Shares (as defined below) outstanding as of March 21, 2024, as reported in the prospectus dated March 21, 2024 filed by the Issuer (as defined below) with the Securities and Exchange Commission (the “SEC”) on March 25, 2024 pursuant to Rule 424(b)(1) under the Securities Act of 1933, as amended (the “Final Prospectus”).

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 3 of 10

     

    1 NAMES OF REPORTING PERSONS    
    Grupo Empresarial Angeles, S.A. de C.V.    
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    
    (a) ☐    
    (b) ☐    
    3 SEC USE ONLY    
         
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
    United Mexican States    
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER    
    0    
       
    6 SHARED VOTING POWER    
    4,678,342    
       
    7 SOLE DISPOSITIVE POWER    
    0    
       
    8 SHARED DISPOSITIVE POWER    
    4,678,342    
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
    4,678,342    
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐    
         
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    
    15.6% (1)    
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    
    HC    
       

     

    (2)The calculation assumes that there is a total of 30,000,000 Class A Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 4 of 10

     

    1 NAMES OF REPORTING PERSONS    
    Corpvaza, S.A. de C.V.    
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    
    (a) ☐    
    (b )☐    
    3 SEC USE ONLY    
         
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
    United Mexican States    
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER    
    0    
       
    6 SHARED VOTING POWER    
    4,678,342    
       
    7 SOLE DISPOSITIVE POWER    
    0    
       
    8 SHARED DISPOSITIVE POWER    
    4,678,342    
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
    4,678,342    
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐    
         
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    
    15.6% (3)    
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    
    HC    
       

     

    (3)The calculation assumes that there is a total of 30,000,000 Class A Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 5 of 10

     

           
    1 NAMES OF REPORTING PERSONS    
    Mr. Olegario Vázquez Aldir    
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP    
    (a) ☐    
    (b) ☐    
    3 SEC USE ONLY    
         
    4 CITIZENSHIP OR PLACE OF ORGANIZATION    
    United Mexican States    
       
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER    
    4,678,342    
       
    6 SHARED VOTING POWER    
    0    
       
    7 SOLE DISPOSITIVE POWER    
    4,678,342    
       
    8 SHARED DISPOSITIVE POWER    
    0    
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    
    4,678,342    
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ☐    
         
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)    
    15.6% (4)    
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)    
    HC    
       

     

    (4)The calculation assumes that there is a total of 30,000,000 Class A Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 6 of 10

     

    Item 1(a). Name of Issuer:

     

    Auna S.A. (the “Issuer”)

     

    Item 1(b). Address of Issuer’s Principal Executive Offices:

     

    46A, Avenue J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg

     

    Item 2(a). Name of Person Filing

     

    This Schedule 13G is being filed on behalf of the following:

     

    i.Grupo Angeles Servicios de Salud, S.A. de C.V. (“GASS”);
    ii.Grupo Empresarial Angeles, S.A. de C.V. (“GEA”);
    iii.Corpvaza, S.A. de C.V. (“Corpvaza”); and
    iv.Mr. Olegario Vázquez Aldir (“Mr. Vázquez Aldir”).

     

    GASS, GEA, Corpvaza and Mr. Vázquez Aldir are collectively referred to as the “Reporting Persons.” Mr. Vázquez Aldir directly controls Corpvaza, which controls GEA, which is the parent company of GASS, the direct holder of the securities of the Issuer.

     

    Item 2(b). Address of Principal Business Office or, if None, Residence:

     

    The address of the principal business office of the Reporting Persons is Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700.

     

    Item 2(c). Citizenship:

     

    The Reporting Persons are citizens or incorporated under the laws of the United Mexican States.

     

    Item 2(d). Title of Class of Securities:

     

    Class A Ordinary Shares, nominal value US$0.01 per share (the “Class A Shares”)

     

    Item 2(e). CUSIP Number:

     

    L0415A 103

     

    Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),Check Whether the Person Filing is a:

     

    (a) ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 73c).
    (c) ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.78c).
    (d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) ☐ An investment adviser in accordance with §13d-1(b)(1)(ii)(E).
    (f) ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
    (g) ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
    (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
    (j) ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
      ☐ If this statement is filed pursuant to §240.13d-1(c), check this box.

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 7 of 10

     

    Item 4. Ownership:

     

    Item 4(a). Amount Beneficially Owned:

     

    As of June 28, 2024, the Reporting Persons may be deemed to beneficially own 4,678,342 Class A Shares held directly by GASS.

     

    Item 4(b). Percent of Class:

     

    As of June 28, 2024, the Reporting Persons may be deemed to beneficially own approximately 15.6% of Class A Shares outstanding. This percentage is based on 30,000,000 Class A Shares outstanding as of March 21, 2024, as reported by the Issuer in the Final Prospectus.

     

    Item 4(c). Number of Shares as to which such person has:

     

    (a) Amount Beneficially Owned:
    See responses to Item 9 on each cover page.
     
    (b) Percent of Class:
    See responses to Item 11 on each cover page.
     
    (c) Number of Shares as to Which Such Person Has:

     

      (i) Sole Power to Vote or to Direct the Vote:
      See responses to Item 5 on each cover page.
       
      (ii) Shared Power to Vote or to Direct the Vote:
      See responses to Item 6 on each cover page.
       
      (iii) Sole Power to Dispose or to Direct the Disposition of:
      See responses to Item 7 on each cover page.
       
      (iv) Shared Power to Dispose or to Direct the Disposition of:
      See responses to Item 8 on each cover page.

     

    Item 5. Ownership of Five Percent or Less of a Class:

     

    As of the date hereof, the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities: ☐.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person:

     

    This Item 6 is not applicable.

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 8 of 10

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

     

    This Item 7 is not applicable.

     

    Item 8. Identification and Classification of Members of the Group:

     

    This Item 8 is not applicable.

     

    Item 9. Notice of Dissolution of Group:

     

    This Item 9 is not applicable.

     

    Item 10. Certification:

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 9 of 10

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    June 28, 2024

     

      Grupo Angeles Servicios de Salud, S.A. de C.V.
       
      /s/ Jose Luis Alberdi Gonzalez  
      Name: Jose Luis Alberdi Gonzalez
      Title: Legal Vice President
       
       
      Grupo Empresarial Angeles, S.A. de C.V.
       
      /s/ Jose Luis Alberdi Gonzalez  
      Name: Jose Luis Alberdi Gonzalez
      Title: Legal Vice President
       
      Corpvaza S.A. de C.V.
       
      /s/ Jose Luis Alberdi Gonzalez  
      Name: Jose Luis Alberdi Gonzalez
      Title: Legal Vice President
       
       
      Olegario Vázquez Aldir
       
      /s/ Jose Luis Alberdi Gonzalez  
      Name: Jose Luis Alberdi Gonzalez (5)
      Title: Authorized Signatory
             

     

    (5)Jose Luis Alberdi Gonzalez is signing on behalf of Mr. Vázquez Aldir pursuant to a power of attorney dated April 12, 2024, which was previously filed with the Commission as an exhibit to a Schedule 13G filed by Mr. Vázquez Aldir on April 12, 2024 (SEC File No. 005-94489).

     

     
     
     

     

     

    CUSIP No. L0415A 103 Page 10 of  10

     

    EXHIBIT INDEX

     

    Exhibit 1 Joint Filing Agreement
    Exhibit 2 Power of Attorney

     

     

     

     

     

     
     
    Get the next $AUNA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AUNA

    DatePrice TargetRatingAnalyst
    5/22/2025$7.90Buy → Hold
    HSBC Securities
    4/23/2024$12.60Buy
    HSBC Securities
    4/16/2024$16.00Overweight
    JP Morgan
    4/16/2024$14.00Overweight
    Morgan Stanley
    More analyst ratings

    $AUNA
    SEC Filings

    See more
    • SEC Form 6-K filed by Auna SA

      6-K - AUNA S.A. (0001799207) (Filer)

      6/6/25 4:16:25 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by Auna SA

      6-K - AUNA S.A. (0001799207) (Filer)

      5/20/25 4:23:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form EFFECT filed by Auna SA

      EFFECT - AUNA S.A. (0001799207) (Filer)

      5/8/25 12:15:17 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Leadership Updates

    Live Leadership Updates

    See more
    • Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda

      3/7/25 8:00:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se

      12/19/24 9:01:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"

      9/3/24 11:30:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Auna S.A. downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Auna S.A. from Buy to Hold and set a new price target of $7.90

      5/22/25 10:32:04 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • HSBC Securities initiated coverage on Auna S.A. with a new price target

      HSBC Securities initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $12.60

      4/23/24 6:12:32 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on Auna S.A. with a new price target

      Morgan Stanley initiated coverage of Auna S.A. with a rating of Overweight and set a new price target of $14.00

      4/16/24 7:35:01 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Auna Announces 1Q25 Financial Results

      Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 ("first quarter 2025" or "1Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 1Q25 Consolidated Highlights Consolidated Revenue decreased 3% YoY to S/1,042 million, increasing +4% FXN Adjusted EBITDA decreased 8% YoY to S/

      5/20/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued a

      5/7/25 7:17:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Proposed Offering of Additional 10.000% Senior Secured Notes Due 2029

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it intends to offer additional 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued as additional notes under the indenture dated as of December 18, 2023 (as amended a

      5/6/25 9:12:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Financials

    Live finance-specific insights

    See more
    • Auna Announces 1Q25 Financial Results

      Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 ("first quarter 2025" or "1Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 1Q25 Consolidated Highlights Consolidated Revenue decreased 3% YoY to S/1,042 million, increasing +4% FXN Adjusted EBITDA decreased 8% YoY to S/

      5/20/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Reporting Dates for First Quarter 2025 Financial Results

      Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2025 financial results. Earnings Release Tuesday, May 20, 2025 Time: After Market Close Conference Call Wednesday, May 21, 2025 Time: 8:00 a.m. ET Quiet Period Monday, April 28 through Tuesday, May 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexic

      4/14/25 8:30:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces 4Q24 and FY 2024 Financial Results

      Adjusted EBITDA increases 20.1% FXN in FY 2024 and Net Operating Cash Flows increase 15% YoY Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 ("fourth quarter 2024" or "4Q24") and full year ended 2024 ("full-year 2024" or "FY24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 4Q24 Consolidated Highlights Consolidated Revenue increased 4% YoY to S/1,063 million, or +11% FXN Adjusted EBIT

      3/10/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Auna SA

      SC 13G - AUNA S.A. (0001799207) (Subject)

      11/14/24 2:22:37 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Auna SA

      SC 13G/A - AUNA S.A. (0001799207) (Subject)

      11/13/24 10:53:24 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Auna SA

      SC 13G - AUNA S.A. (0001799207) (Subject)

      11/12/24 6:09:04 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care